DRUG DELIVERY TECHNOLOGY TRENDS
Rapidly changing technology presents challenges at every stage
of the drug delivery design process. The regulatory stage is no different. Currently, regulators are working to adapt their process to
meet the challenges created by an ever-increasing pace of innovation and development while, at the same time, ensuring high
standards for patient safety remain in place.
From a designer’s point of view, it can feel like you’re pushing
water uphill. You wish it could all move faster. From a regulatory
point of view, the top priority is being very, very careful to make
sure the device enhancing the delivery of the medication will do
no harm to patients. The process of approving drug delivery systems for patient use must be thorough. Currently, the two sides
are working hard to find a balance, in order to achieve the common goal of getting new technology into the hands of patients as
safely and as rapidly as possible.
There are many question marks in the digital drug delivery industry. The biggest one always has been and always will be: “What’s
next?” In my opinion, one of the things we’re going to see in the
not-too-distant future is targeted therapies for cancer patients.
For instance, technological advances in the area of inhala-
tion drug delivery could bring drastic improvements to the fight
against lung cancer. We know we have the ability to reach the
lungs and put the treatment in the optimal place. As we see im-
proved treatments, such as genetic matching of therapies to pa-
tients, the opportunities to help patients that once had little hope
for survival will only continue to grow.
Over time, all drug delivery is going to be heavily influenced by
technology. This is the future, plain and simple. At the end of
the day, it is about getting the drug into the body in the most
efficient and effective way possible. Technology will make that
easier, more reliable, and ultimately provide better overall patient outcomes.
For me personally, it is fantastic to see technology and drug
delivery come together. I started my career as a computer scientist at a time when healthcare innovation was centered on“big
iron”—large, expensive systems focused on solving a narrow
set of challenges. Now we’re using the phones in our pocket to
bring that innovation to everyone. CP
SAM VAN Alstyne is new products marketing manager at 3M
Drug Delivery Systems.
Going further to bring better todays
to even more people with cancer
Visit us at CPhI Worldwide 2017
Frankfurt, 24-26 October
At Helsinn Advanced Synthesis SA, Biasca,
Through our know-how, R&D expertise and solid
CMC approach, we are the right partner from
development through to registration, validation
and commercial manufacturing.
Tel. + 41 (0) 91 873. 94. 00